Cargando…
Cardiovascular implications of COVID-19 versus influenza infection: a review
BACKGROUND: Due to the overlapping clinical features of coronavirus disease 2019 (COVID-19) and influenza, parallels are often drawn between the two diseases. Patients with pre-existing cardiovascular diseases (CVD) are at a higher risk for severe manifestations of both illnesses. Considering the hi...
Autores principales: | Khan, Muhammad Shahzeb, Shahid, Izza, Anker, Stefan D., Solomon, Scott D., Vardeny, Orly, Michos, Erin D., Fonarow, Gregg C., Butler, Javed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746485/ https://www.ncbi.nlm.nih.gov/pubmed/33334360 http://dx.doi.org/10.1186/s12916-020-01816-2 |
Ejemplares similares
-
Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020) -
Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017) -
Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
por: Shahid, Izza, et al.
Publicado: (2022) -
Ten‐Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020) -
Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)